Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Lepelley

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
American Journal of Respiratory and Critical Care Medicine|February 4, 2014
Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancerClaire Germain, Sacha Gnjatic, Fella Tamzalit, et al.
Nature Communications|March 3, 2026
Pharmacological stabilization of hypoxia-inducible factor 1-α dampens the interferon response and promotes glycolysis in Aicardi-Goutières syndromeMaxime Batignes, Marine Luka, Surabhi Jagtap, et al.
Journal of Clinical Immunology|February 7, 2024
Interface Gain-of-Function Mutations in TLR7 Cause Systemic and Neuro-inflammatory DiseaseClémence David, Mihaly Badonyi, Robin Kechiche, et al.
Nature Communications|November 2, 2023
ARF1 prevents aberrant type I interferon induction by regulating STING activation and recyclingMaximilian Hirschenberger, Alice Lepelley, Ulrich Rupp, et al.
The Journal of Experimental Medicine|June 13, 2024
Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupusClémence David, Carlos A Arango-Franco, Mihaly Badonyi, et al.
The Journal of Experimental Medicine|August 13, 2021
Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3AAlice Lepelley, Erika Della Mina, Erika Van Nieuwenhove, et al.
The Journal of Clinical Investigation|January 4, 2024
Heterozygous mutations in the C-terminal domain of COPA underlie a complex autoinflammatory syndromeSelket Delafontaine, Alberto Iannuzzo, Tarin M Bigley, et al.
Journal of Clinical Immunology|December 5, 2022
Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation BiomarkersMathilde Labouret, Stefania Costi, Vincent Bondet, et al.
The Journal of Experimental Medicine|July 30, 2020
Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signalingAlice Lepelley, Maria José Martin-Niclós, Melvin Le Bihan, et al.
Rheumatology (Oxford, England)|November 23, 2019
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signallingIsabelle Melki, Hervé Devilliers, Cyril Gitiaux, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Respiratory and Critical Care Medicine|February 4, 2014
Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancerClaire Germain, Sacha Gnjatic, Fella Tamzalit, et al.
Nature Communications|March 3, 2026
Pharmacological stabilization of hypoxia-inducible factor 1-α dampens the interferon response and promotes glycolysis in Aicardi-Goutières syndromeMaxime Batignes, Marine Luka, Surabhi Jagtap, et al.
Journal of Clinical Immunology|February 7, 2024
Interface Gain-of-Function Mutations in TLR7 Cause Systemic and Neuro-inflammatory DiseaseClémence David, Mihaly Badonyi, Robin Kechiche, et al.
Nature Communications|November 2, 2023
ARF1 prevents aberrant type I interferon induction by regulating STING activation and recyclingMaximilian Hirschenberger, Alice Lepelley, Ulrich Rupp, et al.
The Journal of Experimental Medicine|June 13, 2024
Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupusClémence David, Carlos A Arango-Franco, Mihaly Badonyi, et al.
The Journal of Experimental Medicine|August 13, 2021
Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3AAlice Lepelley, Erika Della Mina, Erika Van Nieuwenhove, et al.
The Journal of Clinical Investigation|January 4, 2024
Heterozygous mutations in the C-terminal domain of COPA underlie a complex autoinflammatory syndromeSelket Delafontaine, Alberto Iannuzzo, Tarin M Bigley, et al.
Journal of Clinical Immunology|December 5, 2022
Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation BiomarkersMathilde Labouret, Stefania Costi, Vincent Bondet, et al.
The Journal of Experimental Medicine|July 30, 2020
Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signalingAlice Lepelley, Maria José Martin-Niclós, Melvin Le Bihan, et al.
Rheumatology (Oxford, England)|November 23, 2019
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signallingIsabelle Melki, Hervé Devilliers, Cyril Gitiaux, et al.
Pageof 4